Hej "w"
-
Hej "w"
Spændende link, prøv også at læse hvad der står under figuren, meget positivt:o)Jeg håber Genmab går målrettet efter af få DARA på markedet som monoterapi i refraktær MM. Lykkes det, tror jeg meget vel DARA kan "lave en rituximab" indenfor myelomatose. Dvs med et stort off-label salg i de øvrige indikationer, da der (ligesom med ritux i sin tid) er tale om en helt ny og effektiv behandling, der formentligt kan tillægges i 1. 2. 3.linje behandling.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind